BSX FY 2012 Earnings — Boston Scientific Corporation Revenue & Financial Results | Market Cap Arena

BSXBoston Scientific Corporation

$102B

FY 2012 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$7.2B-4.9% YoY

Gross Profit

$4.6B62.9% margin

Operating Income

$994M13.7% margin

Net Income

-$4.1B-56.1% margin

EPS (Diluted)

$-2.89

Cash Flow

Operating Cash Flow

$1.3B

Free Cash Flow

$1.0B

Stock-Based Comp.

$108M

Balance Sheet

Total Assets

$17.2B

Total Liabilities

$10.3B

Stockholders' Equity

$6.9B

Cash & Equivalents

$207M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$7.2B	$7.6B	-4.9%
Gross Profit	$4.6B	$4.7B	-2.6%
Operating Income	$994M	$1.1B	-11.5%
Net Income	-$4.1B	$441M	-1022.4%